Features
Benefits:
- Antibiotic sensitivity 96
- Plasma protein binding (82 to 93%)
Effectiveness compare to Sulbactam1
Pathogen
- Pseudomonas Aeruginosa
- Escherichia Coli.
- Klebsiella
Cefoperazone + Tazobactum
- Susceptible
- 96% Susceptible
- 83% Susceptible
Cefoperazone + Sulbactum
- Resistant
- 89% Susceptible
- 67% Susceptible
Indications:
- Acute & Chronic Mastitis
- Respiratory Tract Infections
Intra Uterine Infection
Other Soft tissues Infection
Dosage:
- 5-10mg Cefoperazone/kg B.W. by I/M,I/V route
-
4.5 GM
-
In Stock
-
Injection
Related Products
